NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rna Diagnostics Inc.

Rna Diagnostics Inc.

Private
Toronto, OntarioHealthcare & Life Scienceshttps://rnadiagnostics.com/

Last Round

Grant

Feb 5, 2026

Total Funding Raised

$11.6M

Company Overview

Rna Diagnostics Inc. is a molecular diagnostics company that has developed the Veridapt DX™ predictive biomarker platform to guide oncology treatment decisions by measuring tumor response to cancer drugs.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

molecular diagnosticsprecision oncologyRNA Disruption AssayRDAtreatment response predictioncancer diagnosticslab developed testLDTpredictive biomarker platformRNA diagnosticsbreast cancer diagnosticspersonalized cancer therapysolid tumor diagnosticsCLIA certified labcompanion diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rna Diagnostics Inc. Comps

Public and private peers based on sector, stage, and business model.

Rna Diagnostics Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Rna Diagnostics Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 5, 2026
Series A ExtensionSep 9, 2021
Series ANov 8, 2018
AngelAug 27, 2015

Key People

Founding team and executive leadership

John Jordan

Chief Financial Officer

Executive Team

Rna Diagnostics Inc. Investors

Notable investors and investment history

Rna Diagnostics Inc. investors
InvestorRounds
Ontario Bioscience Innovation OrganizationSeries A
BDC CapitalSeries A Extension
iGan PartnersSeries A, Series A Extension
Northern Ontario Heritage Fund CorporationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 4, 2025

    Monthly visitors grew 143% MoM, reaching 1.1K.

  • Jun 2, 2025

    Monthly visitors increased 212% MoM, from 145 to 453.

Rna Diagnostics Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Rna Diagnostics Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Rna Diagnostics Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Employee Range12
Year Founded2010
Last FundingFeb 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.